The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The optimal anticoagulation strategy for COVID-19, prophylactic or therapeutic?: a meta-analysis, trial sequential analysis, and meta-regression of more than 27,000 participants

Published:2022-09 Issue:3 Volume:2 Page:148-166
ISSN:2097-0617
Container-title:Emergency and Critical Care Medicine
language:en
Short-container-title:Emerg Crit Care Med

Author:

Guo Mingyue,Han Qi,Xing Jiaxuan,Xu Feng,Wang Jiali,Li Chuanbao,Shan Zechen,Bian Yuan,Wang Hao,Xue Li,Yuan Qiuhuan,Pan Chang,De Yanshan,Wang Xingfang,Hao Panpan,Cao Shengchuan,Pang Jiaojiao,Chen Yuguo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Emergency Medicine,Critical Care and Intensive Care Medicine

Reference78 articles.

1. Efficacy and tolerability of bevacizumab in patients with severe COVID-19;Nat Commun,2021

2. Current evidence of interleukin-6 signaling inhibitors in patients with COVID-19: a systematic review and meta-analysis;Front Pharmacol,2020

3. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines;Open Biol,2020

4. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2;Circ Res,2020

5. Hypercoagulability and thrombosis in COVID-19: a modifiable cause for mortality?;Eur Heart J,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP